Reconsidering Mandatory Opioid Prescriber Education Through a Risk Evaluation and Mitigation Strategy (REMS) in an Evolving Crisis
Please join the Duke-Margolis Center for Health Policy and the FDA for a two-day virtual public workshop that will convene regulators, clinical researchers, providers, patient advocates, and other stakeholders to exchange information and obtain input by discussing prescriber education's potential role in alleviating the evolving opioid and substance abuse crisis. Participants will discuss the current landscape of the crisis, the state of opioid prescriber education, recent trends in opioid prescribing and pain management, the current state of opioid prescriber education requirements and opportunities to improve them, the potential role of prescriber education in alleviating the crisis, considerations for the future role of mandatory prescriber education through a REMS, and next steps for opioid prescriber education.